Diabetes Care 28:1228-1230, 2005
© 2005 by the American Diabetes Association, Inc.
Metabolic Syndrome/Insulin Resistance Syndrome/Pre-Diabetes Brief Report |
Concentrations of Serum Vitamin D and the Metabolic Syndrome Among U.S. Adults
Earl S. Ford, MD, MPH1,
Umed A. Ajani, MBBS, MPH1,
Lisa C. McGuire, PHD1 and
Simin Liu, MD, SCD2,3
1 Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
2 Division of Preventive Medicine, Brigham and Womens Hospital and Harvard Medical School, Boston, Massachusetts
3 Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts
Address correspondence and reprint requests to Earl Ford, MD, MPH, Centers for Disease Control and Prevention, 4770 Buford Highway, MS K66, Atlanta, GA 30341. E-mail: eford@cdc.gov
Abbreviations: 25(OH-D), 25-hydroxyvitamin D
| The first 20% of the full text of this article appears below. |
 |
INTRODUCTION
|
|---|
Accumulating research suggests that circulating concentrations of vitamin D may be inversely related to the prevalence of diabetes (1,2,3,4), to the concentration of glucose (4,5,6,7,8), and to insulin resistance (4,5,8,9). In addition, vitamin D deficiency may be a risk factor for the metabolic syndrome (8,10), a highly prevalent condition among U.S. adults (11). Much remains to be learned, however, about the relationship between vitamin D status and metabolic syndrome. Because this topic has received scant attention and the available information was derived from a small clinically based sample, we sought to examine the nature and strength of the association between serum concentrations of vitamin D and the metabolic syndrome in a large nationally representative sample of the U.S. population.
 |
RESEARCH DESIGN AND METHODS
|
|---|
Between 1988 and 1994, a representative sample of the noninstitutionalized civilian U.S. population, selected using a multistage stratified sampling design, participated in the NHANES III (Third National Health and Nutrition Examination Survey). Survey participants were interviewed and invited for a clinical . . . [Full Text of this Article]
 |
RESULTS
|
|---|
 |
CONCLUSIONS
|
|---|

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. L. Wagner, F. R. Greer, and and the Section on Breastfeeding and Committee on
Prevention of Rickets and Vitamin D Deficiency in Infants, Children, and Adolescents
Pediatrics,
November 1, 2008;
122(5):
1142 - 1152.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H. F. Luderer, L. Lieben, C. Mathieu, and M. Demay
Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
Endocr. Rev.,
October 1, 2008;
29(6):
726 - 776.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. G. Forouhi, J. Luan, A. Cooper, B. J. Boucher, and N. J. Wareham
Baseline Serum 25-Hydroxy Vitamin D Is Predictive of Future Glycemic Status and Insulin Resistance: The Medical Research Council Ely Prospective Study 1990-2000
Diabetes,
October 1, 2008;
57(10):
2619 - 2625.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Melamed, E. D. Michos, W. Post, and B. Astor
25-Hydroxyvitamin D Levels and the Risk of Mortality in the General Population
Arch Intern Med,
August 11, 2008;
168(15):
1629 - 1637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P Reis, D. von Muhlen, and E. R Miller III
Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults.
Eur. J. Endocrinol.,
July 1, 2008;
159(1):
41 - 48.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Melamed, P. Muntner, E. D. Michos, J. Uribarri, C. Weber, J. Sharma, and P. Raggi
Serum 25-Hydroxyvitamin D Levels and the Prevalence of Peripheral Arterial Disease: Results from NHANES 2001 to 2004
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2008;
28(6):
1179 - 1185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Talmor, E. Golan, S. Benchetrit, J. Bernheim, O. Klein, J. Green, and G. Rashid
Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells
Am J Physiol Renal Physiol,
May 1, 2008;
294(5):
F1059 - F1064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. H. de Boer, L. F. Tinker, S. Connelly, J. D. Curb, B. V. Howard, B. Kestenbaum, J. C. Larson, J. E. Manson, K. L. Margolis, D. S. Siscovick, et al.
Calcium Plus Vitamin D Supplementation and the Risk of Incident Diabetes in the Women's Health Initiative
Diabetes Care,
April 1, 2008;
31(4):
701 - 707.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Pittas, J. Lau, F. B. Hu, and B. Dawson-Hughes
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
J. Clin. Endocrinol. Metab.,
June 1, 2007;
92(6):
2017 - 2029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Reis, D. von Muhlen, D. Kritz-Silverstein, D. L. Wingard, and E. Barrett-Connor
Vitamin D, Parathyroid Hormone Levels, and the Prevalence of Metabolic Syndrome in Community-Dwelling Older Adults
Diabetes Care,
June 1, 2007;
30(6):
1549 - 1555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. G. Pittas, S. S. Harris, P. C. Stark, and B. Dawson-Hughes
The Effects of Calcium and Vitamin D Supplementation on Blood Glucose and Markers of Inflammation in Nondiabetic Adults
Diabetes Care,
April 1, 2007;
30(4):
980 - 986.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. D. Michos and R. S. Blumenthal
Vitamin D Supplementation and Cardiovascular Disease Risk
Circulation,
February 20, 2007;
115(7):
827 - 828.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Tuohimaa, L. Tenkanen, H. Syvala, S. Lumme, T. Hakulinen, J. Dillner, and M. Hakama
Interaction of Factors Related to the Metabolic Syndrome and Vitamin D on Risk of Prostate Cancer
Cancer Epidemiol. Biomarkers Prev.,
February 1, 2007;
16(2):
302 - 307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cigolini, M. P. Iagulli, V. Miconi, M. Galiotto, S. Lombardi, and G. Targher
Serum 25-hydroxyvitamin d3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients.
Diabetes Care,
March 1, 2006;
29(3):
722 - 724.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Liu, Y. Song, E. S. Ford, J. E. Manson, J. E. Buring, and P. M. Ridker
Dietary Calcium, Vitamin D, and the Prevalence of Metabolic Syndrome in Middle-Aged and Older U.S. Women
Diabetes Care,
December 1, 2005;
28(12):
2926 - 2932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Ross
Dairy, Vitamin D, and Type 2 Diabetes Mellitus
Arch Intern Med,
November 14, 2005;
165(20):
2434 - 2434.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Singh, R. Chauhan, and P. Kushwah
Haste in Starting Therapy for Depression
J Am Board Fam Med,
September 1, 2005;
18(5):
445 - 445.
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Diabetes Association.
|
|
|